Literature DB >> 15840956

Construction of human Fab library and isolation of monoclonal Fabs with rabies virus-neutralizing ability.

Tadasuke Ando1, Tetsu Yamashiro, Yoshiko Takita-Sonoda, Kazuaki Mannen, Akira Nishizono.   

Abstract

A combinatorial human Fab library was constructed using RNAs from peripheral blood lymphocytes of 6 rabies vaccine-boosted volunteers using pComb3X phagemid vector. The size of the constructed library was approximately 7.0 x 10(7) Escherichia coli transformants. The library was selected against purified rabies virus (RV) virion or purified RV glycoprotein for isolation of phages displaying RVneutralizing human Fab antibody. Among 132 selected clones, two Fab preparations revealed neutralizing activities against RV strain CVS when assayed in the rapid fluorescent focus inhibition test (RFFIT). The Fab preparation EP5G3 exhibited neutralizing activity with an infected cell count reduction of 76% at a dilution of 1: 2, and of 20% at a dilution of 1: 4. The Fab preparation GD2D12 also exhibited neutralizing activity with a 57% reduction at 1: 2 and 41% reduction at 1: 4. In the co-immunoprecipitation using strain CVS, the RV glycoprotein was precipitated in reactions with both Fab preparations. The RV neutralizing ability of the Fab preparations described in the study were not directly correlated with their binding specificity for RV antigens detected by ELISA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840956     DOI: 10.1111/j.1348-0421.2005.tb03735.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  3 in total

1.  Expression and characterization of an enantioselective antigen-binding fragment directed against α-amino acids.

Authors:  Pierre P Eleniste; Heike Hofstetter; Oliver Hofstetter
Journal:  Protein Expr Purif       Date:  2013-07-01       Impact factor: 1.650

2.  Characterization of a human antibody fragment Fab and its calcium phosphate nanoparticles that inhibit rabies virus infection with vaccine.

Authors:  Xinjian Liu; Hong Lin; Qi Tang; Chen Li; Songtao Yang; Zhongcan Wang; Changjun Wang; Qing He; Brian Cao; Zhenqing Feng; Xiaohong Guan; Jin Zhu
Journal:  PLoS One       Date:  2011-05-09       Impact factor: 3.240

Review 3.  The growth and potential of human antiviral monoclonal antibody therapeutics.

Authors:  Wayne A Marasco; Jianhua Sui
Journal:  Nat Biotechnol       Date:  2007-12       Impact factor: 54.908

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.